Barron's

Advertisement

The AI Side Effect

The Tech Resale Market Is Booming. That’s Still Good News for Apple.

The Tech Resale Market Is Booming. That’s Still Good News for Apple.

Consumers are looking to tighten their belts, but the world’s largest electronics company is benefiting nevertheless.

Klarna’s Shopper Growth Gives Battered Shares a Boost

Klarna’s Shopper Growth Gives Battered Shares a Boost

Klarna stock rises after reporting strong customer growth and an increase in transaction margin dollars in the third quarter.

3 minute read

Viking Earnings Still Show Bruises From Summer Slump. Investors Will Have to Wait for Calmer Waters.

Viking Earnings Still Show Bruises From Summer Slump. Investors Will Have to Wait for Calmer Waters.

Viking Holdings misses quarterly earnings and revenue estimates. Investors will need to look past the quarter.

2 minute read

November 16, 2026

Even in Crisis, Nvidia Stock Is Still a Buy

Even in Crisis, Nvidia Stock Is Still a Buy

Nvidia’s stock hasn’t worked for a while now, and that was with Jensen Huang as CEO. His surprise resignation is a chance for investors to reassess.

Long Read

Advertisement

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.

The biotech plans to reinvest in its pipeline, particularly oncology treatments like its personalized cancer vaccine.

3 minute read

Why Pfizer Is Tapping Private Equity to Back Its Once-Monthly Weight-Loss Drug

Why Pfizer Is Tapping Private Equity to Back Its Once-Monthly Weight-Loss Drug

Blackstone Life Sciences agrees to pay $1.5 billion in development costs for Pfizer’s berobenatide through 2028 in exchange for milestone-based payments.

2 minute read

Half of Our ‘Big Money’ Managers Say the AI Boom Has Years Left to Run

Half of Our ‘Big Money’ Managers Say the AI Boom Has Years Left to Run

Optimists cite robust earnings growth; the pessimists see a bubble in danger of bursting. Plus, pro forecasts for rates, international markets, the midterm, and more.

Long Read

Don’t Fret the War. Why ‘Big Money’ Investors Are Bullish—and Where They’re Investing Now.

Don’t Fret the War. Why ‘Big Money’ Investors Are Bullish—and Where They’re Investing Now.

In our latest Big Money poll, professional investors are more upbeat than six months ago and see plenty of opportunities for stocks. Where they’re putting money to work.

Long Read

Airline Stocks Bounce Back as Travel Chaos Eases

Airline Stocks Bounce Back as Travel Chaos Eases

Carriers’ shares got a boost on Monday, as the worst of the weekend’s travel chaos looks to be over.

1 minute read

Why Diamondback Is Betting Billions for a Bigger Cut of Future West Texas Wells

Why Diamondback Is Betting Billions for a Bigger Cut of Future West Texas Wells

Buying out Double Eagle’s 40% stake lets Diamondback capture more revenue from wells it was already planning to drill.

3 minute read

Concurrent Recruits Big Raymond James Team as Assets Surge Nearly 80% in 2026

Concurrent Recruits Big Raymond James Team as Assets Surge Nearly 80% in 2026

The latest addition to Concurrent’s platform continues a year of rapid growth with assets under management now topping $30 billion.

2 minute read

Charles Schwab Tweaks Tax-Smart Investing Strategy—Again

Charles Schwab Tweaks Tax-Smart Investing Strategy—Again

Demand for tax-aware long/short strategies has soared and tested Schwab’s ability to make them available for advisors.

3 minute read

Check out Barron's Advisor Rankings

Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.

Find an Advisor

Are you ready to search for a financial advisor? We'll match you with advisors who can help.

Advertisement

(Eastern Time Zone)

Recently Viewed Tickers

SymbolPriceChange% Chg

Advertisement

U.S. Stock Movers

Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000

Company (Ticker)Change PercentPrice
SELLAS Life Sciences Group Inc. (SLS)159.44% $19.38
Tucows Inc. (TCX)34.02% $15.34
Greenwich LifeSciences Inc. (GLSI)30.67% $17.98
Cingulate Inc. (CING)24.27% $4.66
New Fortress Energy Inc. Cl A (NFE)23.61% $3.77
View full table View extended-hours trading page

Advertisement

Advertisement